Physician-Directed Leadership
Every Peptalys program is designed, supervised, and reviewed under physicianoversight. We build governance and safety into the care pathway
Executive Leadership
.png)
President & Executive Chairman
Flavio Elia
Flavio Elia leads the governance and strategic direction of Peptalys. He oversees corporate structure, institutional alignment, and long-term expansion strategy, ensuring the platform operates within a structured, compliance-first framework.
.png)
Founder & Chief Strategy Officer
Konstantin Kirchfeld
Konstantin Kirchfeld defines the strategic roadmap and long-term vision of Peptalys. He focuses on clinical model design, stakeholder alignment, and the structured expansion of preventive medicine services.
.png)
CEO, Digital Platform & Infrastructure
Stefano Curzio
Stefano Curzio leads the development of the Peptalys digital infrastructure and technology systems. He oversees platform architecture, data systems, and operational scalability to support structured, physician-directed care pathways.
Clinical Leadership
Chief Medical Officer
Appointment in final stages. Interim clinical governance provided via Medical Advisory Board.
Scientific & Clinical Advisory
.png)
Strategic Biotech & Venture Partner
Xlife Sciences AG
Strategic biotech and venture partner supporting translational science and longevity innovation alignment.
.png)
Chief Scientific Officer
Dr. Alexander Zink
Oversees scientific validation strategy and research alignment across longevity programs.
.png)
Chief Financial Officer
Carl von Halem
Provides financial governance and institutional structuring oversight.
.png)
Clinical Innovation & Preventive Medicine Advisor
Dr. Daniele Santurbano
Advises on preventive medicine pathways and protocol development.
.png)
Scientific & Regenerative Medicine Advisor
Dr. Simone Dahlmanns
Strategic biotech and venture partner supporting translational science and longevity innovation alignment.
